Aug 29, 2026 · Sports, Health & Nutrition Daily Digest
A digest of sports, fitness, wellness, and nutrition news compiled for Aug 29, 2026, with summaries, links, and commentary.
I. Nutrition & Diet
1. Head-to-head RCT: At matched ~10% weight loss, keto beats Mediterranean and low-fat plant-forward diets on liver fat and prediabetes remission (Nutrition)
Summary:
Petersen, Klein and colleagues at Washington University School of Medicine report in Cell Metabolism (2026-08-27; DOI: 10.1016/j.cmet.2026.07.020) a randomized trial: 55 adults with obesity, prediabetes, and fatty liver enrolled (42 completed), assigned to ketogenic (~4% energy from carbohydrate, ~73% fat), Mediterranean (~50% carbohydrate, ~35% fat), or very-low-fat plant-forward (~70% carbohydrate, ~15% fat) diets; all food provided, weekly dietitian visits, calories adjusted so each group lost ~10% body weight over ~4–5 months. Muscle insulin sensitivity rose ~50% in all groups, with similar body-fat and several CV-risk improvements; liver fat fell ~67% on keto vs ~45% in the other two arms; hepatic insulin sensitivity improved ~2–3× more on keto; prediabetes remission was ~50% (keto) vs 29% (Mediterranean) and 7% (plant-forward). Small sample and high adherence under food provision; long-term feasibility and hard outcomes remain open.
Links:
- ScienceDaily — Keto diet cut liver fat by 67% (2026-08-29)
- Cell Metabolism — Effect of diet macronutrient content… (DOI: 10.1016/j.cmet.2026.07.020)
- WashU Medicine — Low-carb diet delivers added liver benefits
Commentary:
If you have fatty liver plus prediabetes and medical clearance for lower carbohydrate intake, treat liver-fat reduction as a goal beyond the scale; if adherence and food variety matter more, Mediterranean or plant-forward patterns still improve muscle insulin sensitivity at the same weight loss—pick what you can sustain.
2. Prospective cohort meta-analysis: Higher fermented milk, cheese, and chocolate intake linked to lower all-cause/CVD mortality (Nutrition)
Summary:
Frontiers in Nutrition (DOI: 10.3389/fnut.2026.1714437) pooled 50 cohorts (>3 million adults) comparing highest vs lowest fermented-food intake and mortality. Higher fermented milk (including yogurt) associated with all-cause mortality pooled RR ~0.941, CVD mortality ~0.932, and cancer mortality ~0.940; yogurt alone ~0.933 for all-cause; cheese ~0.970 for all-cause; chocolate ~0.901 for all-cause (higher heterogeneity). Miso and bread showed no significant associations. Observational meta-analysis—residual confounding and healthy-user bias remain; effect sizes are mostly single-digit percentages and are not causal prescriptions.
Links:
- Frontiers in Nutrition — Fermented foods and mortality meta-analysis
- [your]NEWS — Review links fermented foods to lower death risk (2026-08-28)
Commentary:
Plain or lightly sweetened yogurt and moderate cheese are reasonable everyday fermented/protein choices; do not read “chocolate and lower mortality” as license for sugary confection—categories compare intake extremes, not candy binges.
II. Exercise & Training Science
3. Mechanistic study: Exercise-induced L-BAIBA mediates muscle adaptation and performance via a PGC1α–BAIBA–PPARδ axis (Training)
Summary:
Roberts and colleagues (University of Leeds) show in Nature Communications (2026-08-18; DOI: 10.1038/s41467-026-76307-8) that skeletal-muscle PGC-1α driven by training biosynthesizes and secretes the metabokine β-aminoisobutyric acid (BAIBA); the L-enantiomer regulates muscle metabolism, morphology, and function via PPARδ and determines exercise performance in mice; knocking down its biosynthetic enzyme impairs training adaptations. In human myotubes, L-BAIBA acts through Mas-related G-protein-coupled receptor D on fiber-type markers; human plasma L-BAIBA correlates with aerobic fitness and rises with endurance training. BAIBA also mitigated muscle dysfunction in a mouse diabetes model. Core evidence is animal/in vitro; this paper does not establish large human supplement RCTs with hard endpoints.
Links:
- Nature Communications — BAIBA mediates exercise performance (DOI: 10.1038/s41467-026-76307-8)
- University of Leeds — Muscle-boosting molecule released during exercise
- EurekAlert! — Muscle-boosting molecule released during exercise
Commentary:
For most people the actionable message is still regular endurance plus resistance training to drive these signals—not treating over-the-counter L-BAIBA as a proven “exercise mimetic” drug.
4. 24-week RCT: In elite track athletes, complex training lifts jump height and eccentric strength more; contrast training shortens push-off time (Training)
Summary:
A Jimei University–led team reports in Journal of Strength & Conditioning Research (August 2026 issue; DOI: 10.1519/JSC.0000000000005451) a trial of 45 national-level male track and field athletes randomized to complex training (postactivation potentiation emphasis; ~1–3 min rests), contrast training (postactivation performance enhancement; ~4–10 min rests), or control—three ~90-minute sessions/week for 24 weeks, assessed on a 3D force plate. With arm swing, complex training raised jump height ~30.9% (~0.55→0.72 m) vs ~17.1% contrast and ~7.7% control; drop height also favored complex. Without arm swing, contrast cut push-off time ~6.1% and raised push-off power ~17.1%, outperforming complex. Eccentric strength explained ~43% of jump-height variance. Elite male sample only—dose and progression must be scaled for non-elites.
Links:
- JSCR / Ovid — Complex and contrast training in elite track athletes
- Strength Science — Complex vs. Contrast Training
Commentary:
Favor complex (heavy + short-rest plyo) if jump height and landing control are the goal; lengthen contrast rests if sprint start/short ground-contact power matters—amateurs need solid squat/landing skills before either.
III. Guidelines & Public Health
5. AHA/ASA: 2026 adult stroke rehabilitation guideline—start early after stability, address mind and body, include caregivers (Guideline)
Summary:
On 2026-08-27 the American Heart Association/American Stroke Association published the 2026 Guideline for Adult Stroke Rehabilitation and Recovery in Stroke (DOI: 10.1161/STR.0000000000000536), replacing the 2016 version. Key points: begin personalized rehab as soon as medically stable, ideally within 48 hours in hospital; avoid moderate-to-high-intensity exercise or task practice in the first 24 hours after stroke. Care should cover motor, cognitive, communication, and mental health needs with regular depression/anxiety screening; teams may include neurology, rehab nursing, PT/OT, speech-language pathology, social work, and psychology. Recovery can continue months to years without a fixed endpoint and needs periodic goal reassessment; ~2.7 million caregivers should be included in education and support.
Links:
- AHA Newsroom — Stroke rehab should start early… (2026-08-27)
- Stroke — 2026 Guideline for Adult Stroke Rehabilitation (DOI: 10.1161/STR.0000000000000536)
Commentary:
After a loved one’s stroke, ask when rehab starts, who screens mood, and what the post-discharge path is—do not push hard training in the first 24 hours, and do not delay rehab once stable.
6. STAREE large RCT: Atorvastatin primary prevention in ≥70s without known CVD cuts major CV events ~30% (Public health)
Summary:
The STAREE double-blind placebo-controlled trial led by Zoungas (Monash University) was presented in an ESC Congress 2026 Hot Line on 2026-08-29 and published simultaneously in NEJM (DOI: 10.1056/NEJMoa2607314). Australian general practice recruited 9,971 community-dwelling adults ≥70 years without clinical CVD, diabetes, or dementia (mean age ~74.7; ~52% women), randomized to atorvastatin 40 mg daily or placebo; median follow-up ~5.9 years. Major CV events (CV death, nonfatal MI, stroke, or coronary revascularization) occurred in 6.0% vs 8.3% (HR 0.70, 95% CI 0.61–0.82; NNT ~37). The co-primary of disability-free survival (free of dementia and persistent physical disability) was not significantly improved (HR 0.94, p=0.25). Muscle, liver, and diabetes-related adverse events were more common on statin; serious adverse events were uncommon (~2.7% both arms).
Links:
- ESC — Atorvastatin cuts major CV events 30% in older adults (2026-08-29)
- NEJM — STAREE (DOI: 10.1056/NEJMoa2607314)
- The Guardian — Statins cut risk in healthy over-70s (2026-08-29)
Commentary:
Adults ≥70 without prior CVD can discuss MI/stroke prevention benefits versus myalgia, liver enzymes, and new diabetes risk with a clinician—do not expect statins alone to extend disability-free survival; lifestyle and comorbidity care still matter.
7. REACT: Silent atherosclerosis is common in asymptomatic adults—about 1 in 13 aged 18–29 already have plaque (Public health)
Summary:
Bundgaard, Ibáñez and colleagues reported REACT Phase 1 at ESC 2026 Hot Line with simultaneous NEJM publication (DOI: 10.1056/NEJMoa2609059): 16,808 people aged 18–70 in Denmark and Spain without known atherosclerotic CVD underwent carotid/femoral ultrasound and coronary CTA. Overall ~57.1% had atherosclerotic plaque in at least one artery; ~1 in 13 of those aged 18–29 were affected, rising to ~9 in 10 at ages 60–70. Prevalence rose earlier in men; women showed a steeper midlife rise around typical menopause age. In younger participants, disease was often peripheral and single-territory; isolated coronary disease was uncommon at all ages. Cross-sectional prevalence atlas—imaging positive ≠ inevitable events; whether imaging-guided prevention beats risk-score care awaits later randomized phases.
Links:
- MedicalXpress — Silent artery plaques before age 30 (2026-08-29)
- NEJM — Prevalence of Silent Atherosclerosis across Adult Life (DOI: 10.1056/NEJMoa2609059)
- News-Medical — Silent atherosclerosis in healthy young adults
Commentary:
For young adults, blood pressure, lipids, smoking, sleep, and weight deserve attention in the 20s—not only after symptoms; universal imaging screening is not guideline-standard yet—people with risk factors should use formal CV assessment rather than DIY CT.
IV. Sleep & Mental Health
8. Healthy midlife adults: More frequent nocturnal micro-awakenings linked to higher Alzheimer’s polygenic risk (Sleep)
Summary:
University of Liège (GIGA Neurosciences) researchers report in SLEEP (DOI: 10.1093/sleep/zsag143; covered ~2026-08-28) analyses of sleep EEG and Alzheimer’s polygenic risk scores in >500 healthy adults. In midlife participants (reports cite mean ~59 years; also 50–69 subgroup framing), more frequent micro-awakenings—brief EEG arousals that need not fully wake the sleeper—tracked with higher polygenic risk; the link was absent in younger adults. Findings intersect locus coeruleus vulnerability and sleep regulation but are associative only—they do not predict individual disease or support clinical screening.
Links:
- ScienceDaily — Sleep may hide early Alzheimer’s clue (2026-08-28)
- SLEEP — Sleep arousals and polygenic AD risk (DOI: 10.1093/sleep/zsag143)
- MedicalXpress — Sleep disturbances linked to genetic Alzheimer’s risk
Commentary:
Midlife “light, fragmented” sleep with daytime sleepiness warrants evaluation for apnea, insomnia, and schedule issues—treat sleep quality as a modifiable brain-health lever; do not read one bad night or a consumer wearable as an Alzheimer’s warning.
V. Evidence Clarification / Sports Medicine
9. ESC observational analysis: Higher blood xylitol levels associated with greater major adverse cardiovascular event risk (Evidence)
Summary:
Witkowski (Charité) and colleagues presented at ESC Congress 2026 data from ~17,710 people in CLSA and EPIC-Norfolk prospective cohorts comparing highest vs lowest fasting blood xylitol quartiles. After adjustment for age, sex, smoking, lipids, diabetes, and hypertension, the top quartile had ~57% higher MACE (death, MI, or stroke) risk over ~6 years in CLSA and ~18% higher over ~30 years in EPIC-Norfolk, with a dose-related pattern across middle quartiles. Prior mechanistic work suggested xylitol can heighten platelet reactivity. Observational—levels reflect diet, endogenous metabolism, and confounding; occasional sugar-free gum ≠ top-quartile exposure.
Links:
- ESC — Xylitol may increase the risk of cardiovascular events
- The Guardian — Xylitol linked to strokes and heart attacks (2026-08-28)
- MedicalXpress — Xylitol may increase cardiovascular events
Commentary:
If you lean on large volumes of xylitol-sweetened “zero” products for sugar control, cut total intake and return to whole-food carbohydrate management; CV-risk patients need not panic over one piece of gum, nor treat sugar alcohols as unlimited-safe sweetness.
10. Consumer Reports: 15 of 17 OTC prenatal vitamins missed labeled nutrient amounts (Supplements)
Summary:
Consumer Reports (published 2026-08-19; updated ~2026-08-24) tested 17 OTC prenatals for label accuracy and arsenic/cadmium/lead/mercury: only trace metals in 3 products; but 15/17 had at least one key nutrient (including folate, iron, calcium, vitamins A/C/D/E, etc.) above or below label claims—about 31% of 124 nutrient assays outside acceptable tolerance; 4 of 8 gummies had folate well below label. Only a few (e.g., Carlyle For Her Prenatal; Bird&Be Complete Prenatal Pack) aligned with labeled amounts. Independent spot-check—not every market lot.
Links:
Commentary:
For pregnancy planning, prefer clinician-guided folate/prenatals with third-party testing or pharmacy channels over marketing claims alone—especially verify folate potency in gummy formats.
11. Systematic review: Neuromuscular training for ACL prevention in female athletes—implementation quality (≥2×/week, etc.) may matter as much as the program (Sports medicine)
Summary:
Frontiers in Public Health (DOI: 10.3389/fpubh.2026.1743075) used a SWiM framework across 13 studies (n=2,847) on real-world neuromuscular training (NMT: ≥2 of plyometrics, strength, balance/proprioception, agility, etc.) in female athletes. Implementation quality tracked with effectiveness; one high-quality study linked ≥2 NMT sessions/week in amateur female soccer to large ACL risk reduction (HR 0.15, 95% CI 0.03–0.73)—frequency threshold still needs cross-setting validation. Stakeholder-engaged models with professional support achieved ~73.5%–85.6% compliance vs weaker education-only approaches; schools often outperformed community settings. Time, coach load, and weak ongoing support were key barriers. Few studies reported ACL-specific outcomes.
Links:
Commentary:
For teams and self-coached ball sports, bake strength/landing/cutting into warm-ups at least twice weekly with quality oversight—better than downloading a prevention PDF that never gets done.
Today's Summary
- Nutritionally, keto’s extra liver-fat and prediabetes benefits at matched weight loss are RCT-backed, while fermented dairy offers modest long-term mortality associations—match macros to metabolic phenotype and pick patterns you can sustain.
- Training science (L-BAIBA mechanisms; elite complex vs contrast RCT) stresses signals and programming details (rest, arm swing, eccentric strength), not supplement slogans.
- Same-day ESC/NEJM STAREE and REACT advance primary prevention at both ends—statins in healthy older adults and a life-course map of silent plaque—while AHA stroke rehab guidance pushes early, whole-person care.
- Sleep micro-arousals vs AD genetic risk, xylitol observational signals, and prenatal-label audits all demand calibrated evidence strength before behavior change.
Daily Framing:
A day of macronutrient-specific metabolic gains, dual public-health advances on aging hearts and youthful silent plaque, and training cues that favor mechanisms plus implementation quality over hype.
This digest is compiled from real-time search results and is for reference only.